๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for SCC - Squamous Cell Carcinoma

Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma NCT06342167Phase 210 sites๐Ÿ“ Beijing๐Ÿ“ Fujian๐Ÿ“ Handan Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Radiotherapy, Programmed Cell Death Protein 1 Inhibitor, Immunonutrition support Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC) NCT07190755NA2 sites๐Ÿ“ Rouen๐Ÿ“ Vandล“uvre-lรจs-Nancy Centre Henri Becquerel ยท Tests: Remote symptoms moniotring Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma NCT07125755Phase 37 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou๐Ÿ“ Guilin Sun Yat-sen University ยท Tests: Cisplatin Adebrelimab ยฑInduction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC NCT06510660Phase 21 site๐Ÿ“ Fuzhou Fujian Medical University Union Hospital ยท Tests: adebrelimab Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC NCT05085496Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Atezolizumab, Stereotactic Body Radiation Therapy 3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial NCT05674396Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Stereotactic body radiotherapy, Traditional Palliation A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors NCT05208762Phase 162 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Birmingham Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046054, pembrolizumab TIL Therapy in cSCC and MCC NCT07288073Phase 21 site๐Ÿ“ Boston Karam Khaddour, MD, MS ยท Tests: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2 Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma NCT06755567n/a1 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: MRI-based radiomics-clinical model Registry Platform Gastric/Esophageal Cancer (SAPHIR) NCT04290806n/a1 site๐Ÿ“ Multiple Locations iOMEDICO AG ยท Tests: Routine care as per site standard VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer NCT04057209NA4 sites๐Ÿ“ Paris๐Ÿ“ Mumbai๐Ÿ“ Bern Olgun Elicin ยท Tests: Single Vocal Cord Irradiation (SVCI), Arm A: Transoral CO2-Laser Microsurgical Cordectomy (TLM) Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors NCT07360314Phase 19 sites๐Ÿ“ New Haven๐Ÿ“ Huntersville๐Ÿ“ Galveston EMD Serono Research & Development Institute, Inc. ยท Tests: M7437, M7437 A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma NCT06753747Phase 1, Phase 21 site๐Ÿ“ Chengdu West China Hospital ยท Tests: Palbociclib, Afatinib(30mg), Afatinib(40mg), Afatinib(RP2D) Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study NCT07437898Phase 21 site๐Ÿ“ Putian The Affiliated Hospital of Putian University ยท Tests: Adebrelimab, chemotherapy Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome NCT06380686n/a2 sites๐Ÿ“ Essen๐Ÿ“ Hanover AIO-Studien-gGmbH ยท Tests: data collection Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma NCT07595770Phase 21 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: โ€ข Adebrelimab and nab-paclitaxel, carboplatin in Combination With radiotherapy Cutaneous Squamous Cell Carcinoma Staging Study NCT05695222n/a2 sites๐Ÿ“ London๐Ÿ“ London Queen Mary University of London ยท Tests: This is not an interventional study Improved Oral Health in Head and Neck Cancer Survivors NCT07173270NA1 site๐Ÿ“ Uppsala Uppsala University ยท Tests: Oral health support Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel NCT06947668n/a1 site๐Ÿ“ Erlangen University of Erlangen-Nรผrnberg Medical School Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence NCT06692556Phase 328 sites๐Ÿ“ Le Puy-en-Velay๐Ÿ“ Pierre-Bรฉnite๐Ÿ“ Dijon Centre Leon Berard ยท Tests: Adjuvant radiotherapy STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision NCT05576831NA1 site๐Ÿ“ Vancouver British Columbia Cancer Agency ยท Tests: Re-excision Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients NCT02139020n/a5 sites๐Ÿ“ Ottignies๐Ÿ“ Charleroi๐Ÿ“ Haine-Saint-Paul Cliniques universitaires Saint-Luc- Universitรฉ Catholique dโ€ฆ ยท Tests: Plasma samples Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer NCT06173986Phase 1, Phase 21 site๐Ÿ“ Shanghai Shanghai Chest Hospital ยท Tests: PD-1inhibitor, nab-paclitaxel + cisplatin, Radiotherapy EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC NCT07617805Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EGFR/HER2 Dual-Target CAR-NK Cells, Fludarabine, Cyclophosphamide Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy NCT05793151NA4 sites๐Ÿ“ St Louis๐Ÿ“ Durham๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: ENDURE Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma NCT07601737Phase 21 site๐Ÿ“ Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Scโ€ฆ ยท Tests: Nimotuzumab Injection, Tislelizumab, Albumin-Bound Paclitaxel /nab-Paclitaxel, Cisplatin (Or Carboplatin), Radical surgโ€ฆ Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma NCT07217028Phase 11 site๐Ÿ“ Nashville Vanderbilt-Ingram Cancer Center ยท Tests: Cetuximab (EGFR inhibitor), 18F-NOTA-ABY-030, Positron Emission Tomography (PET) AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy NCT06494995Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: Cadonilimab, Low-dose radiotherapy, SBRT, Capecitabine Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer NCT07180901NA1 site๐Ÿ“ Montreal Centre hospitalier de l'Universitรฉ de Montrรฉal (CHUM) ยท Tests: Proactive Risk-Based Optimization and Notifications for Treatment and Outcomes (PRONTO) Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer NCT05172245Phase 118 sites๐Ÿ“ Tampa๐Ÿ“ Chicago๐Ÿ“ Fairway National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Cisplatin, Computed Tomography, Ipatasertib
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy